Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Blood

Volumn 107, Issue 8, 2006, Pages 3074-3080

  Couriel, Daniel R ^a   Hosing, Chitra ^a   Saliba, Rima ^a   Shpall, Elizabeth J ^a   Anderlini, Paolo ^a   Rhodes, Beverly ^a   Smith, Veronica ^a   Khouri, Issa ^a   Giralt, Sergio ^a   De Lima, Marcos ^a   Hsu, Yvonne ^a   Ghosh, Shubhra ^a   Neumann, Joyce ^a   Andersson, Borje ^a   Qazilbash, Muzzafar ^a   Hymes, Sharon ^a   Kim, Stella ^a   Champlin, Richard ^a   Donato, Michele ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; DACLIZUMAB; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOXSALEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; THALIDOMIDE; TSUKUBAENOLIDE; UVADEX;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BREAST CANCER; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FEVER; ERYTHROCYTE TRANSFUSION; EVALUATION; EXTRACORPOREAL CIRCULATION; EYE; FEMALE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; LIVER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUTH MUCOSA; OUTCOMES RESEARCH; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SKIN; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNIVARIATE ANALYSIS;

EID: 33645733724     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-09-3907     Document Type: Article

References (29)

1. Couriel D, Caldera H, Champlin R, Komanduri K. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer. 2004;101:1936-1946.
2. Lee SJ, Vogelsang G, Flowers ME. Chronic graftversus-host disease. Biol Blood Marrow Transplant. 2003;9:215-233.
3. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14-21.
4. Couriel DR, Saliba R, Escalon MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol. 2005;130:409-417.
5. Demierre MF, Foss FM, Koh HK. Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations: Boston, Massachusetts, Oct. 1 and 2, 1994. J AmAcad Dermatol. 1997;36:460-466.
6. Gottlieb SL, Wolfe JT, Fox FE, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol. 1996;35:946-957.
7. Evans AV, Wood BP, Scarisbrick JJ, et al. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response. Blood. 2001;98:1298-1301.
8. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996;35:573-579.
9. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Transfus Apheresis Sci. 2003;29:61-70.
10. Knobler R, Girardi M. Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann N Y Acad Sci. 2001;941:123-138.
11. Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92:3098-3104.
12. Sniecinski IPP, Dagis A, Smith B. Extracorporeal photopheresis (EP) is effective treatment for chronic refractory graft versus host disease. Blood. 1998;92:454a. Abstract 1877.
13. Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23:881-887.
14. Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41:1299-1305.
15. Apisarnthanarax N, Donato M, Korbling M, et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant. 2003;31:459-465.
16. Abhyankar S, Bishop M. Adjunctive treatment of resistant chronic graft-versus-host disease with extracorporeal photopheresis, using UVADEX Sterile Solution [abstract]. Blood. 1998;92:454a. Abstract 1876.
17. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267-276.
18. Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Demeocq F. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apheresis Sci. 2003;28:71-80.
19. Halle P, Paillard C, D'Incan M, et al. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Res. 2002;11:501-512.
20. Ullrich SE. Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versushost disease across major histocompatibility barriers. J Invest Dermatol. 1991;96:303-308.
21. Foss FM, Gorgun G, Miller KB. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant. 2002;29:719-725.
22. Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol. 1999;107:707-711.
23. Di Renzo M, Rubegni P, Sbano P, et al. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family. Arch Dermatol Res. 2003;295:175-182.
24. Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol. 2004;150:1055-1060.
25. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood. 2002;100:941-947.
26. Lee S, Dorken B, Schmitt CA. Extracorporeal photopheresis in graft-versus-host disease: ultraviolet radiation mediates T cell senescence in vivo. Transplantation. 2004;78:484-485.
27. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood. 2003;102:1217-1223.
28. Craciun LI, Stordeur P, Schandene L, et al. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation. 2002;74:995-1000.
29. Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988;72:555-561.